Neumora Therapeutics, Inc. Common StockNMRANASDAQ
LOADING
|||
Net Income Contraction
Below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-243.79M
↓ 29% below average
Average (4y)
$-189.44M
Historical baseline
Range
High:$-99.27M
Low:$-243.79M
CAGR
+25.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-243.79M | -3.3% |
| 2023 | $-235.93M | -80.2% |
| 2022 | $-130.90M | +44.8% |
| 2021 | $-237.31M | -139.1% |
| 2020 | $-99.27M | - |